The overall tone shows a positive acknowledgment of the publication's importance, with many users discussing detailed mechanisms like myocardial cell stretching and the progression of CKD-related cardiovascular risk, which reflects both high interest and moderate engagement. Terms like 'exploring,' 'review,' and references to future screenings and therapies underline the perceived significance and potential impact of this research on clinical awareness and patient health.
AgreementModerate agreement
Most discussions recognize the significance of the publication, highlighting the link between cardiovascular issues and CKD, indicating general support and understanding of its importance.
InterestHigh interest
The discussions demonstrate high curiosity, with multiple posts mentioning ongoing research, future prospects, and calls for screening, reflecting strong interest.
EngagementModerate engagement
Posts show moderate engagement, including references to specific mechanisms like volume expansion leading to LVH and discussions about the pathophysiology, suggesting users are exploring the content more deeply.
ImpactModerate impact
The prominence of the article in social discussions and emphasis on screening and senior implications suggest it could influence awareness and clinical practices, though not overwhelmingly so.
Abstract in brief
Patients with chronic kidney disease (CKD) are at a much higher risk for cardiovascular issues like coronary artery disease, heart failure, arrhythmias, and sudden cardiac death, with the risk increasing as CKD progresses.
The elevated cardiovascular risk in CKD is due to systemic inflammation, which leads to damage and aging of blood vessels and the heart, causing problems like atherosclerosis, vascular calcification, and myocardial fibrosis.
CKD is the leading cause of death in these patients, especially in later stages, and the disease mimics accelerated aging of the cardiovascular system, emphasizing the need for understanding and managing cardiovascular health in CKD.
Revisión que analiza enfermedad renal y sistema cardiovascular. Una vez que se inicia y progresa la enfermedad renal, se acelera el envejecimiento de nuestro sistema cardiovascular. https://t.co/51rLjqYl3J https://t.co/5yTax4zEjy
Mar 20, 2021 · 15 likes · 8 shares · 1,081 followersView post →
Stage 5 kidney disease, also known as uremic catastrophe, is a life-threatening emergency requiring immediate treatment. When kidney function drops below an eGFR of 15, toxins accumulate, causing symptoms like nausea…
This episode explores how chronic inflammation links kidney disease with cardiovascular risk, contributing to vascular damage, high blood pressure, and artery hardening. We discuss current challenges and emerging…
ORGAN CROSSTALKS
✍️Interaction of cardiovascular disease (CVD) and chronic kidney disease (CKD)
✍️We’ve evolved so much
✍️But we’ve yet so much un unveil
1️⃣2021: https://t.co/HJOkFsW3wm
2️⃣2025: https://t.co/BnODgVMi4T https://t.co/nkjJm4avA1
Jun 30, 2025 · 3 likes · 2,307 followersView post →
Professor Joachim Jankowski and team published an article on @CircAHA exploring the elevated risk of #cardiovascular diseases in patients with #CKD. 9 in 10 patients do not know they have CKD.
Have you gotten #screened?
#kidneydisease #healthscreening
https://t.co/FOSHzBRVDu
May 18, 2022 · 3 likes · 1 share · 1,060 followersView post →
VC
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X
RT @ckd_ce: 19) Volume expansion results in stretching of the myocardial cells. Together, higher afterload and preload propels the developm…
19) Volume expansion results in stretching of the myocardial cells. Together, higher afterload and preload propels the development of LVH. 10.1161/CIRCULATIONAHA.120.050686 https://t.co/VyvxTcNnIw
Nov 2, 2021 · 3 likes · 2,647 followersView post →
VC
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X
RT @cardiomet_CE: 19) Volume expansion results in stretching of the myocardial cells. Together, higher afterload and preload propels the de…
Oct 11, 2021 · 1 share · 9,815 followersView post →
AA
Ala Ali
@alanephro · X
RT @cardiomet_CE: 19) Volume expansion results in stretching of the myocardial cells. Together, higher afterload and preload propels the de…
19) Volume expansion results in stretching of the myocardial cells. Together, higher afterload and preload propels the development of LVH. 10.1161/CIRCULATIONAHA.120.050686 https://t.co/ukZl87lxAD
Oct 11, 2021 · 6 likes · 1 share · 4,218 followersView post →
X
@xguerrat
@xguerrat · X
RT @JonathanNefro: Recordemos que el riesgo de muerte cardiovascular de un joven de 25 años en diálisis es el mismo que el que tiene un anc…
RT @jarubiogarcia: Revisión que analiza enfermedad renal y sistema cardiovascular. Una vez que se inicia y progresa la enfermedad renal, se…
Mar 20, 2021 · 8 shares · 3,351 followersView post →
JR
José Antonio Rubio
@jarubiogarcia · X
Revisión que analiza enfermedad renal y sistema cardiovascular. Una vez que se inicia y progresa la enfermedad renal, se acelera el envejecimiento de nuestro sistema cardiovascular. https://t.co/51rLjqYl3J https://t.co/5yTax4zEjy
Mar 20, 2021 · 15 likes · 8 shares · 1,081 followersView post →
O
Ovocita ✨
@elibeteli · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 170 followersView post →
DB
Dr. Alex M. Benevides
@alxbenevides · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 2,264 followersView post →
AU
Andrés Urrutia
@AndresAUrrutia · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 118 followersView post →
DS
Dr. Luiz Silva
@DrLuizSilva1 · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 398 followersView post →
CL
Cardiorenal Lab.
@Cardiorenal_Lab · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 338 followersView post →
JB
Justin P. Van Beusecum
@Jvanbeusecum · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 1,042 followersView post →
CF
Carmen De Miguel, PhD, MS, FAHA
@Carmendemigue12 · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 3,377 followersView post →
IP
Indonesian Heart Association PERKI
@inaheartperki · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 2,371 followersView post →
BD
baetz delphine
@BaetzDelphine · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 84 followersView post →
GM
GK85MD
@GK85MD · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 780 followersView post →
HG
humberto_gmr
@gmr_humberto · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 558 followersView post →
L
Lancellotti
@cardiopole · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 1,618 followersView post →
抗
抗血栓療法
@antithrombosis · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 131 followersView post →
C日
Circulation 日本版
@Circulation_nih · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 353 followersView post →
SG
Shinya Goto
@sgoto4 · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 325 followersView post →
MS
Magda Sierra
@arreispm · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 253 followersView post →
MT
Muhammad Tahir
@tauhair · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 239 followersView post →
DF
(Dr) Lorna Fiedler
@FiedlerLorna · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 477 followersView post →
HR
Hany Ragy
@Hragy · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 80,752 followersView post →
AF
Alex Kharlamov MD FESC FACC FEACVI FAHA
@drskharlamov · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 19, 2021 · 37 shares · 1,671 followersView post →
TP
Tiago Peçanha
@tiagopecanha · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 1,607 followersView post →
RG
Rodrigo Gopar
@rodrigogopar · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 1,248 followersView post →
MP
Matiram Pun
@PunMatiram · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 1,533 followersView post →
M
Miguel
@EinhellBlake · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 54 followersView post →
MG
Manuel Gaxiola
@cardiogax · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 7,990 followersView post →
LM
Lin Lin Myat
@linlin_m · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 67 followersView post →
PI
PARCC-INSERM
@parcc_inserm · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 1,076 followersView post →
CR
Cardio-Rafa
@cardiopeople · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 95 followersView post →
GF
Gina Lundberg MD FACC FAHA
@gina_lundberg · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 12,380 followersView post →
SS
Sarah Sattin
@SarahSattin_ · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 738 followersView post →
DE
Dr. Álvaro Herrera E
@heralv1985 · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 1,102 followersView post →
E
exlocus
@exlocus · X
RT @CircAHA: #InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/b…
Mar 18, 2021 · 37 shares · 293 followersView post →
C
Circulation
@CircAHA · X
#InDepth: Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options https://t.co/bq02JNHptx #AHAJournals https://t.co/WK8aGv6Z9h
Mar 18, 2021 · 98 likes · 37 shares · 77,798 followersView post →
C
CarolPs
@CarolPS1984 · X
RT @ValleAlfonso: ⚠️Gran revisón de: “CV Disease in Chronic Kidney Disease”
Mar 18, 2021 · 55 shares · 119 followersView post →
SM
SEMERGEN Murcia
@SEMERGENMurcia · X
RT @ValleAlfonso: ⚠️Gran revisón de: “CV Disease in Chronic Kidney Disease”
Mar 18, 2021 · 55 shares · 574 followersView post →
DK
Dra Karla
@KarlaPoot4 · X
RT @ValleAlfonso: ⚠️Gran revisón de: “CV Disease in Chronic Kidney Disease”
Mar 17, 2021 · 55 shares · 82 followersView post →
GL
Gabi LS
@erudainthur · X
RT @ValleAlfonso: ⚠️Gran revisón de: “CV Disease in Chronic Kidney Disease”
Mar 17, 2021 · 55 shares · 50 followersView post →
JY
Jesus Yibirin
@jgy_vascular · X
RT @ValleAlfonso: ⚠️Gran revisón de: “CV Disease in Chronic Kidney Disease”
Mar 17, 2021 · 55 shares · 453 followersView post →
KL
KIN LOPEZ
@KINWAHSIU · X
RT @ValleAlfonso: ⚠️Gran revisón de: “CV Disease in Chronic Kidney Disease”
Mar 17, 2021 · 55 shares · 188 followersView post →
GG
Gino Gomez
@gino1087 · X
RT @ValleAlfonso: ⚠️Gran revisón de: “CV Disease in Chronic Kidney Disease”
Mar 17, 2021 · 55 shares · 1,068 followersView post →
MV
Marta Varas❣️
@VarasMayoral · X
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.
https://t.co/RXzGPnDey3
The UK's first and only Experimental Arthritis Treatment Centre for Children. We are a unique consortium delivering research (from early lab-based studies to ...